Method for identification of Tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof

Details for Australian Patent Application No. 2004251462 (hide)

Owner TXCELL

Inventors Groux, Herve

Agent Freehills

Pub. Number AU-B-2004251462

PCT Pub. Number WO2005/000344

Priority 03/07601 24.06.03 FR

Filing date 24 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 19 May 2011

International Classifications

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/000344 Priority application(s): WO2005/000344

19 May 2011 Application Accepted

  Published as AU-B-2004251462

2 June 2011 Corrigenda

  Applications Accepted - Name Index Under the name TXCELL, Application No. 2004251462, under INID (54) correct the title to read Method for identification of Tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof

4 August 2011 Corrigenda

  Applications Accepted - Name Index Under the name TXCELL, Application No. 2004251462, under INID (72) add co-inventor Foussat, Arnaud

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251466-Use of pyrazolopyridines for the treatment of cognitive deficits

2004251457-Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof